Business Context and Reporting Period
Company: Bristol-Myers Squibb Company (BMY)
Filing Type: Form 8-K (Current Report)
Date of Report: February 5, 2026
Reporting Period: Fourth Quarter and Full Year 2025
This filing serves as a notification that the Company has issued an Earnings Press Release and a presentation regarding its financial results for Q4 and full-year 2025. The detailed financial data is contained within the attached exhibits (Exhibit 99.1 and 99.2) and is not explicitly detailed in the body of this 8-K form.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, and Liquidity: The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are disclosed in the Earnings Press Release (Exhibit 99.1) and the Bristol Myers Presentation (Exhibit 99.2), which are incorporated by reference but not reproduced in this summary text.
Material Changes
Comparison to Prior Period: The filing text does not provide specific data on material changes versus the prior comparable period. Investors must refer to the attached Earnings Press Release for year-over-year comparisons and operational updates.
Guidance, Outlook, and Risks
- Management Commentary: The Company posted a presentation on its website detailing financial and operating initiatives available during the conference call held on February 5, 2026.
- Non-GAAP Measures: The Earnings Press Release and Presentation include non-GAAP financial information. Reconciliations to GAAP measures are available in the Press Release.
- Regulatory Disclosure: The information in Item 7.01 (Regulation FD Disclosure) is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities thereof, except as specifically provided in future filings.
- Availability: The Company reserves the right to discontinue the availability of the presentation materials from its website at any time.
Investor Verification Checklist
- Verify the specific Q4 and full-year 2025 revenue and net income figures in Exhibit 99.1 (Earnings Press Release).
- Review the reconciliation of non-GAAP financial measures to GAAP measures provided in the Press Release.
- Confirm the details of the "financial and operating initiatives" outlined in Exhibit 99.2 (Presentation Materials).
- Check the Company's website (www.bms.com) to ensure the presentation materials remain available, as the Company reserves the right to remove them.
- Review the conference call transcript for management's forward-looking guidance and commentary on the 2025 results.